Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangbin Lim

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
JTO Clinical and Research Reports|September 30, 2021
Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and SavolitinibSun Min Lim, San-Duk Yang, Sangbin Lim, et al.
Cell & Bioscience|April 19, 2016
Regulation of mitochondrial functions by protein phosphorylation and dephosphorylationSangbin Lim, Kelly R Smith, Ssang-Taek Steve Lim, et al.
Frontiers in Immunology|July 28, 2018
Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-MetabolismAnusha Angajala, Sangbin Lim, Joshua B Phillips, et al.
Cancer Research|March 2, 2017
Interplay between Immune Checkpoint Proteins and Cellular MetabolismSangbin Lim, Joshua B Phillips, Luciana Madeira da Silva, et al.
The British Journal of Nutrition|June 17, 2011
Antioxidant enzymes induced by repeated intake of excess energy in the form of high-fat, high-carbohydrate meals are not sufficient to block oxidative stress in healthy lean individualsSangbin Lim, Hyeran Won, Yeonghwan Kim, et al.
Planta Medica|June 20, 2006
Involvement of nuclear factor-kappaB in the inhibition of pro-inflammatory mediators by pinosylvinJongsung Lee, Eunsun Jung, Jihee Lim, et al.
Antioxidants & Redox Signaling|September 10, 2011
Peroxiredoxin-2 upregulated by NF-κB attenuates oxidative stress during the differentiation of muscle-derived C2C12 cellsHyeran Won, Sangbin Lim, Miran Jang, et al.
Molecular Cancer Therapeutics|September 18, 2020
Osimertinib, an Irreversible Next-Generation EGFR Tyrosine Kinase Inhibitor, Exerts Antitumor Activity in Various Preclinical NSCLC Models Harboring the Uncommon EGFR Mutations G719X or L861Q or S768INicolas Floc'h, Sangbin Lim, Sue Bickerton, et al.
Oncotarget|February 6, 2016
Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylationYue Jin, Qingsong Cai, Anitha K Shenoy, et al.
Cancer Research|June 22, 2012
Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxideMiran Jang, Yeonghwan Kim, Hyeran Won, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
JTO Clinical and Research Reports|September 30, 2021
Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and SavolitinibSun Min Lim, San-Duk Yang, Sangbin Lim, et al.
Cell & Bioscience|April 19, 2016
Regulation of mitochondrial functions by protein phosphorylation and dephosphorylationSangbin Lim, Kelly R Smith, Ssang-Taek Steve Lim, et al.
Frontiers in Immunology|July 28, 2018
Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-MetabolismAnusha Angajala, Sangbin Lim, Joshua B Phillips, et al.
Cancer Research|March 2, 2017
Interplay between Immune Checkpoint Proteins and Cellular MetabolismSangbin Lim, Joshua B Phillips, Luciana Madeira da Silva, et al.
The British Journal of Nutrition|June 17, 2011
Antioxidant enzymes induced by repeated intake of excess energy in the form of high-fat, high-carbohydrate meals are not sufficient to block oxidative stress in healthy lean individualsSangbin Lim, Hyeran Won, Yeonghwan Kim, et al.
Planta Medica|June 20, 2006
Involvement of nuclear factor-kappaB in the inhibition of pro-inflammatory mediators by pinosylvinJongsung Lee, Eunsun Jung, Jihee Lim, et al.
Antioxidants & Redox Signaling|September 10, 2011
Peroxiredoxin-2 upregulated by NF-κB attenuates oxidative stress during the differentiation of muscle-derived C2C12 cellsHyeran Won, Sangbin Lim, Miran Jang, et al.
Molecular Cancer Therapeutics|September 18, 2020
Osimertinib, an Irreversible Next-Generation EGFR Tyrosine Kinase Inhibitor, Exerts Antitumor Activity in Various Preclinical NSCLC Models Harboring the Uncommon EGFR Mutations G719X or L861Q or S768INicolas Floc'h, Sangbin Lim, Sue Bickerton, et al.
Oncotarget|February 6, 2016
Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylationYue Jin, Qingsong Cai, Anitha K Shenoy, et al.
Cancer Research|June 22, 2012
Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxideMiran Jang, Yeonghwan Kim, Hyeran Won, et al.
Pageof 3